Quick Answer
KIORA PHARMACEUTICALS INC reported Stockholders Equity of $16.13 million for fiscal year 2025.
KIORA PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $16.13M | -37.4% |
| 2024 | $25.76M | +321.6% |
| 2023 | $6.11M | -46.4% |
| 2022 | $11.41M | -21.8% |
| 2021 | $14.58M | +49.8% |
| 2020 | $9.73M | +46.9% |
| 2019 | $6.62M | -25.9% |
| 2018 | $8.94M | +563.8% |
| 2017 | -$1.93M | -484.9% |
| 2016 | -$329.4K | -105.4% |
| 2015 | $6.09M | +113.0% |
| 2014 | -$46.81M | -4.4% |
| 2013 | -$44.84M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $22.41M | -25.4% | +1.3% |
| June 30, 2025 | $22.13M | -33.2% | -6.6% |
| March 31, 2025 | $23.70M | -32.1% | -8.0% |
| December 31, 2024 | $25.76M | +321.6% | -14.2% |
| September 30, 2024 | $30.03M | +270.6% | -9.3% |
| June 30, 2024 | $33.10M | +142.6% | -5.2% |
| March 31, 2024 | $34.90M | +243.7% | +471.3% |
| December 31, 2023 | $6.11M | -46.4% | -24.6% |
- KIORA PHARMACEUTICALS INC showed a decrease of -37.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2025 period, KIORA PHARMACEUTICALS INC’s stockholders equity has grown by 136.0% (from -$44.84 million to $16.13 million).
- The most recent figure is from KIORA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: